VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ONMDOneMedNet Corporation
$0.66$36M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksONMDBalance Sheet

OneMedNet Corporation (ONMD) Balance Sheet

6Y historyFree accessUpdated daily

The company's financial position is severely constrained, evidenced by a current ratio of 0.27 and a negative equity balance of $4.1 million in 2026Q1.

ONMD Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20
Total Current Assets1.46M2.1M3.62M364.19K391K833.29K293.62K
Cash & Short-Term Investments233K1.09M3.02M47.01K271K699.32K79.18K
Cash Only233K585K172K47.01K271K699.32K79.18K
Short-Term Investments0506K2.85M0000
Accounts Receivable697K495K213K151.64K19K91.74K195.37K
Days Sales Outstanding140.3132.95120.9154.216.0130.6786.54
Inventory0000000
Days Inventory Outstanding-------
Other Current Assets530K509K385K165.54K101K42.23K19.07K
Total Non-Current Assets47K56K108K98.87K898K49.77K34.3K
Property, Plant & Equipment47K56K108K98.87K83K49.77K34.3K
Fixed Asset Turnover22.64x24.27x5.95x10.33x13.89x21.94x24.03x
Goodwill0000000
Intangible Assets0000000
Long-Term Investments0000000
Other Non-Current Assets0000815K00
Total Assets1.51M2.15M3.73M463.06K1.29M883.06K327.91K
Asset Turnover0.70x0.63x0.17x2.20x0.89x1.24x2.51x
Asset Growth %3.54%-42.29%704.87%-64.08%45.97%169.3%-
Total Current Liabilities5.36M4.83M19.23M12.83M26.1M4.75M1.55M
Accounts Payable006.37M4.18M1.18M00
Days Payables Outstanding--2.52K1.33K283.94--
Short-Term Debt0350K8.76M4.64M24.74M3.35M1.05M
Deferred Revenue (Current)2.35M389K561K254K184K642.35K106.37K
Other Current Liabilities4.68M3.79M283K00758.82K391.12K
Current Ratio0.27x0.43x0.19x0.03x0.01x0.18x0.19x
Quick Ratio0.27x0.43x0.19x0.03x0.01x0.18x0.19x
Cash Conversion Cycle140.3------
Total Non-Current Liabilities231K291K449K489.61K1.54M1.83M1.64M
Long-Term Debt0220K0465.02K1.5M1.55M1.55M
Capital Lease Obligations0000000
Deferred Tax Liabilities0000000
Other Non-Current Liabilities231K71K449K24.58K44K287.61K93.19K
Total Liabilities5.59M5.12M19.68M13.32M27.65M6.59M3.19M
Total Debt0570K8.76M5.1M26.24M4.9M2.6M
Net Debt-233K-15K8.59M5.05M25.97M4.2M2.52M
Debt / Equity-0.00x------
Debt / EBITDA-0.00x------
Net Debt / EBITDA0.02x------
Interest Coverage-74.22x-40.79x-67.89x-3068.27x-75.46x-14.05x-
Total Equity-4.08M-2.96M-15.95M-12.86M-26.36M-5.7M-2.86M
Equity Growth %309.14%81.41%-24.03%51.21%-362.23%-99.42%-
Book Value per Share-0.07-0.07-0.57-1.82-2.17-0.38-0.19
Total Shareholders' Equity-4.08M-2.96M-15.95M-12.86M-26.36M-5.7M-2.86M
Common Stock5K2K2K2.36K0434383
Retained Earnings-106.82M-104.37M-101.57M-55.08M-57.66M-25.31M-22.37M
Treasury Stock0-529K-529K0000
Accumulated OCI0000000
Minority Interest0000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and solvency risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Persistent Erosion of Equity Base

As reported in recent financial statements, ONMD's equity position has remained consistently negative, with the deficit reaching $4.1 million in 2026Q1, reflecting a multi-quarter trend of capital depletion that underscores the company's ongoing struggle to achieve a sustainable, value-accretive business trajectory.

The persistent negative equity suggests that the company has been unable to retain earnings or generate sufficient capital to offset its operational losses. This trajectory indicates that the business model is currently consuming its own capital base, which may necessitate further dilutive financing to maintain operations.

Leverage Dynamics and Refinancing Risks

Based on the provided balance sheet data, the company has successfully reduced its total debt from a peak of $9.7 million in 2024Q2 to zero as of 2026Q1, though this deleveraging appears to be a necessity-driven response to severe liquidity constraints rather than a strategic capital structure optimization.

While the absence of debt in the most recent quarter may appear positive, it likely reflects the company's inability to access credit markets or the exhaustion of previous debt facilities. Investors should monitor whether the firm can secure non-dilutive capital, as the current lack of leverage leaves little room for error in funding ongoing operations.

Critical Cash Runway and Solvency

According to quarterly filings, the company's liquidity position remains precarious, with a cash balance of only $233,000 in 2026Q1 and a current ratio of 0.27, indicating that current assets are significantly insufficient to cover the firm's immediate short-term obligations.

The extremely low current ratio suggests that the company is operating with a severe working capital deficit, which may impair its ability to meet operational commitments. This liquidity profile warrants extreme caution, as it implies that the company is highly dependent on the timing of cash inflows to avoid a potential solvency crisis.

Hidden Risks in Asset Composition

As indicated by the balance sheet, the company's asset base is remarkably thin, with total assets of only $1.5 million in 2026Q1, of which a negligible portion is represented by net PPE, suggesting that the firm lacks the tangible collateral necessary to support traditional financing.

The lack of significant tangible assets or goodwill suggests that the company's value is almost entirely tied to its intangible network and data curation capabilities, which are difficult to monetize in a distressed scenario. This asset-light structure, while potentially scalable, provides no buffer against operational shocks or the need for emergency capital.

ONMD — Frequently Asked Questions

Quick answers to the most common questions about buying ONMD stock.

What are the total assets of OneMedNet Corporation (ONMD)?

As of 2025, OneMedNet Corporation (ONMD) had total assets of $2.2M including $2.1M in current assets.

How much debt does OneMedNet Corporation (ONMD) have?

OneMedNet Corporation (ONMD) carries total debt of $0.6M, offset by $1.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of OneMedNet Corporation?

OneMedNet Corporation (ONMD) has total shareholders' equity (book value) of $-3.0M ($-0.07 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is OneMedNet Corporation's current ratio and liquidity?

OneMedNet Corporation (ONMD) reported a current ratio of 0.43x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.